Torsemide Pa 915 50111 0915 01 Medication Summary
No separate FDA Medication Guide was found for this label. This summary is based on FDA/DailyMed prescribing information.
What is this medication?
This medication is described in FDA/DailyMed prescribing information. No separate FDA Medication Guide was found for this label. This summary is based on FDA/DailyMed prescribing information.
What is this medication used for?
Torsemide tablets are a loop diuretic indicated for: the treatment of edema associated with heart failure, renal disease or hepatic disease. ( 1.1) the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.2)
What should I know before taking it?
Torsemide is contraindicated in patients with known hypersensitivity to torsemide. Torsemide is contraindicated in patients who are anuric. Torsemide is contraindicated in patients with hepatic coma.
What important warnings are listed?
Hypotension and worsening renal function: monitor volume status and renal function periodically ( 5.1) Electrolyte and metabolic abnormalities: monitor serum electrolytes and blood glucose periodically. ( 5.2) Ototoxicity ( 5.3, 7.6)
How is this medication usually taken?
Torsemide Tablets are available as white to off white scored tablets in 5-, 10-, 20-, and 100-mg strengths.
What side effects are listed?
The following risks are discussed in more detail in other sections: Hypotension and Worsening Renal Function [see Warnings and Precautions ( 5.1)] Electrolyte and Metabolic Abnormalities [see Warnings and Precautions ( 5.2)] Ototoxicity [see Warnings and Precautions ( 5.3)]
What interactions are listed?
Non-steroidal anti-inflammatory drugs (NSAIDs): Reduced diuretic, natriuretic, and antihypertensive effects; risk of renal impairment. ( 7.1) CYP2C9: Concomitant use with CYP2C9 inhibitors can decrease torsemide clearance. Torsemide may affect the efficacy and safety of sensitive CYP2C9 substrates or of substrates with a narrow therapeutic range, such as warfarin or phenytoin. ( 7.2) Cholestyramine: Decreased exposure of torsemide.( 7.3) Organic anion drugs: may decrease diuretic activity of torsemide. ( 7.4) Lithium: Risk of lithium toxicity ( 7.5) Renin-angiotensin inhibitors: Increased risk of hypotension and renal impairment. ( 7.7) Radiocontrast agents: Increased risk of renal.
Where can I find the official prescribing information?
Review the full prescribing information on DailyMed: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7fc14338-92e4-cf57-a3e8-ef64d8d1026c
⚠️ Disclaimer
This summary is for educational purposes only and is not medical advice. Always consult your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine. Read full medical disclaimer.